A recent study on assessment of MSC therapy's efficacy and safety in COVID-19 management revealed that inflammatory indices such as WBC, pro-calcitonin, CRP and IL-6 were unchanged after MSC perfusion; IgG and IgM were also unchanged after MSC therapy. The gene discussed is IL6; the disease is COVID-19.